MCLR logo

Medclair AB Stock Price

NGM:MCLR Community·SEK 271.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

MCLR Share Price Performance

SEK 2.96
0.84 (39.62%)
SEK 2.96
0.84 (39.62%)
Price SEK 2.96

MCLR Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with acceptable track record.

1 Risk
1 Reward

Medclair AB Key Details

SEK 58.8m

Revenue

SEK 19.6m

Cost of Revenue

SEK 39.1m

Gross Profit

SEK 34.7m

Other Expenses

SEK 4.5m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.049
66.58%
7.58%
0%
View Full Analysis

About MCLR

Founded
2005
Employees
15
CEO
Jonas Lundh
WebsiteView website
www.medclair.com

Medclair AB, a research and development company, specializes in the measurement, collection, and destruction of nitrous oxide (N2O) in Sweden. It offers mobile destruction unit, a mobile unit that enables the destruction of nitrous oxide; central destruction unit, an ideal solution for situations where Nitrous Oxide (N2O) is used simultaneously in multiple treatment rooms; Recycling Decomposition Unit, an intelligent solution that effectively collects Nitrous Oxide (N2O) from discarded N2O canisters and decomposes it within a self-supporting system; and EXPO.p, a next-generation exposure monitor that helps professionals track N2O levels. The company serves healthcare, dentistry, recycling, and industrial sectors. Medclair AB was incorporated in 2005 and is based in Stockholm, Sweden.

Recent MCLR News & Updates

Recent updates

No updates